(ZEAL) Zealand Pharma - Performance -29.1% in 12m
Compare ZEAL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
41.65%
#17 in Group
Rel. Strength
21.97%
#5962 in Universe
Total Return 12m
-29.11%
#69 in Group
Total Return 5y
107.58%
#23 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG 0.31
70th Percentile in Group
FCF Yield -2.43%
(unknown) Percentile in Group
12m Total Return: ZEAL (-29.1%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ZEAL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ZEAL
| Total Return (including Dividends) | ZEAL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -23.70% | -5.85% | -3.01% |
| 3 Months | -36.07% | -11.95% | -3.15% |
| 12 Months | -29.11% | -11.00% | 10.19% |
| 5 Years | 107.58% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | ZEAL | XBI | S&P 500 |
| 1 Month | -28.1% | -59.8% | -5.5% |
| 3 Months | -69.1% | -70.5% | -58.4% |
| 12 Months | -13.1% | -6.9% | 84.1% |
| 5 Years | 61.8% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #158 | -19.0% | -21.3% |
| 3 Month | #130 | -27.4% | -34.0% |
| 12 Month | #68 | -20.4% | -35.7% |
| 5 Years | #24 | 106% | -9.45% |
FAQs
Does ZEAL Zealand Pharma outperforms the market?
No,
over the last 12 months ZEAL made -29.11%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ZEAL made -36.07%, while XBI made -11.95%.
Over the last 3 months ZEAL made -36.07%, while XBI made -11.95%.
Performance Comparison ZEAL vs Indeces and Sectors
ZEAL vs. Indices ZEAL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -12.9% | -20.7% | -42.8% | -39.3% |
| US NASDAQ 100 | QQQ | -11.9% | -19.6% | -42.0% | -37.7% |
| US Dow Jones Industrial 30 | DIA | -13.1% | -21.6% | -43.7% | -38.6% |
| German DAX 40 | DAX | -11.6% | -20.3% | -59.6% | -50.8% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12.6% | -23.9% | -27.6% | -38.2% |
| Hongkong Hang Seng | HSI | -14.8% | -26.5% | -33.6% | -46.4% |
| India NIFTY 50 | INDA | -13.9% | -31.6% | -32.5% | -29.8% |
| Brasil Bovespa | EWZ | -13.0% | -32.0% | -34.8% | -17.4% |
ZEAL vs. Sectors ZEAL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.3% | -19.9% | -50.9% | -48.3% |
| Consumer Discretionary | XLY | -13.6% | -19.9% | -46.2% | -43.2% |
| Consumer Staples | XLP | -15.6% | -21.9% | -43.6% | -40.1% |
| Energy | XLE | -13.9% | -31.7% | -48.4% | -29.9% |
| Financial | XLF | -13.3% | -21.0% | -55.0% | -51.4% |
| Health Care | XLV | -13.3% | -20.5% | -38.1% | -30.8% |
| Industrial | XLI | -13.2% | -23.0% | -42.1% | -37.6% |
| Materials | XLB | -14.0% | -24.2% | -34.7% | -25.2% |
| Real Estate | XLRE | -14.9% | -21.0% | -39.7% | -42.5% |
| Technology | XLK | -11.7% | -19.7% | -37.7% | -31.1% |
| Utilities | XLU | -16.1% | -24.5% | -41.9% | -54.3% |
| Aerospace & Defense | XAR | -12.3% | -25.0% | -46.7% | -50.0% |
| Biotech | XBI | -8.29% | -17.9% | -25.1% | -18.1% |
| Homebuilder | XHB | -13.4% | -23.9% | -23.4% | -21.4% |
| Retail | XRT | -15.2% | -23.2% | -38.7% | -24.3% |